Enlivex Therapeutics (ENLV) announced the enrollment and dosing of the first 10 patients in its Phase II Allocetra trial of individuals with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback